Pol1: A Key Enzyme for DNA Replication and Gene Expression (P16224)

Target Name: DNA-Directed RNA Polymerase I

NCBI ID: P16224

DNA-Directed RNA Polymerase I

Other Name(s): Pol1 | POLR1 | POLRI | RNA polymerase I | PolI

Pol1: A Key Enzyme for DNA Replication and Gene Expression

DNA-Directed RNA Polymerase I (Pol1) is a key enzyme in the regulation of gene expression and DNA replication in eukaryotic cells. It is a 25 kDa protein that is expressed in most tissues and is involved in the initiation of DNA replication after transcription. The function of Pol1 is highly conserved across different organisms and is critical for the maintenance of DNA integrity and the expression of gene expression.

One of the unique features of Pol1 is its DNA-directed nature. It has a specific recognition sequence at its leading edge that is essential for DNA binding. This recognition sequence is composed of 13 base pairs and is located upstream of the active site. The sequence is highly conserved across different organisms and is involved in the formation of a stable DNA-protein complex that is critical for the initiation of DNA replication.

In addition to its role in DNA replication, Pol1 is also involved in the regulation of gene expression. It has been shown to play a role in the regulation of gene expression by modifying the accessibility of transcription factors and by affecting the stability of RNA molecules.

One of the most significant findings related to Pol1 is its potential as a drug target. The high degree of conservation of the recognition sequence between Pol1 and its cognate RNA polymerase II (Pol2) suggests that it may be a promising target for small molecules. Several studies have shown that inhibitors of Pol1 have been shown to be effective in inhibiting the activity of Pol1 and that these inhibitors have been shown to have potential therapeutic applications.

Another potential application of Pol1 is as a biomarker for cancer. The expression of Pol1 is often increased in cancer cells compared to normal cells. This increase in Pol1 expression is due to the fact that Pol1 is involved in the regulation of cell growth and division, and is often activated in response to the growth inhibitory effects of chemotherapy. Therefore, the level of Pol1 expression is a sensitive biomarker for cancer diagnosis and monitoring.

In conclusion, DNA-Directed RNA Polymerase I (Pol1) is a key enzyme in the regulation of gene expression and DNA replication in eukaryotic cells. Its DNA-directed nature and role in the regulation of cell growth and division make it a promising target for small molecules and a sensitive biomarker for cancer. Further research is needed to fully understand the function of Pol1 and its potential as a drug and biomarker.

Protein Name: DNA-Directed RNA Polymerase I

The "DNA-Directed RNA Polymerase I Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNA-Directed RNA Polymerase I comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets